Currently holds a position at Catalyst Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chairman of the Board, President, Chief Executive Officer | Catalyst Pharmaceuticals Inc | March 1, 2006 - |
Independent Director | Thermogenesis Holdings Inc | Jan. 1, 2012 - June 19, 2015 |
Lead Independent Director | Thermogenesis Holdings Inc | Jan. 1, 2011 - Jan. 1, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-11-22 | 2022-11-21 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
150,000
-3.7%
15.332,299,800 USD |
150,000 -3.7% | 15.33 | 2,299,800 USD | |
2022-11-22 | 2022-11-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
350,000
-8.2%
15.625,467,700 USD |
350,000 -8.2% | 15.62 | 5,467,700 USD | |
2022-09-15 | 2022-09-14 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
946,846
-19.5%
15.4114,594,684 USD |
946,846 -19.5% | 15.41 | 14,594,684 USD | |
2022-09-15 | 2022-09-13 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
80,765
-1.6%
15.331,238,047 USD |
80,765 -1.6% | 15.33 | 1,238,047 USD | |
2022-08-19 | 2022-08-19 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
125,000
-2.5%
14.101,762,425 USD |
125,000 -2.5% | 14.10 | 1,762,425 USD | |
2022-08-19 | 2022-08-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
50,000
-1.0%
13.95697,550 USD |
50,000 -1.0% | 13.95 | 697,550 USD | |
2022-08-19 | 2022-08-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
50,000
-1.0%
13.96697,950 USD |
50,000 -1.0% | 13.96 | 697,950 USD | |
2022-08-19 | 2022-08-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
50,000
-1.0%
13.93696,500 USD |
50,000 -1.0% | 13.93 | 696,500 USD | |
2022-08-19 | 2022-08-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
25,000
-0.5%
13.93348,350 USD |
25,000 -0.5% | 13.93 | 348,350 USD | |
2019-10-03 | 2019-10-03 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
B Purchase |
10,000
+0.2%
4.8948,900 USD |
10,000 +0.2% | 4.89 | 48,900 USD | |
2019-06-11 | 2019-06-11 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
B Purchase |
25,000
+0.5%
3.2380,750 USD |
25,000 +0.5% | 3.23 | 80,750 USD | |
2009-05-20 | 2009-05-19 |
Thermogenesis Holdings Inc
(THMO)
|
B Purchase |
25,000
+30.4%
0.5814,500 USD |
25,000 +30.4% | 0.58 | 14,500 USD | |
2009-05-12 | 2009-05-08 |
Thermogenesis Holdings Inc
(THMO)
|
B Purchase |
25,000
+43.6%
0.5313,250 USD |
25,000 +43.6% | 0.53 | 13,250 USD | |
2004-12-10 | 2004-12-09 |
Thermogenesis Holdings Inc
(THMO)
|
S Sale |
11,197
-100.0%
5.6763,487 USD |
11,197 -100.0% | 5.67 | 63,487 USD | |
2004-12-10 | 2004-12-08 |
Thermogenesis Holdings Inc
(THMO)
|
S Sale |
8,803
-100.0%
5.8051,057 USD |
8,803 -100.0% | 5.80 | 51,057 USD | |
2004-02-20 | 2004-02-18 |
Thermogenesis Holdings Inc
(THMO)
|
S Sale |
60,000
-58.1%
5.37322,200 USD |
60,000 -58.1% | 5.37 | 322,200 USD |